Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • High-dose opioid prescribing continues to climb in Canada

  • Sleep disorders widely undiagnosed in individuals with multiple sclerosis

  • Unemployment for doctoral scientists, engineers below American national average in 2013

  • Mindfulness protects adults' health from the impacts of childhood adversity

  • Epilepsy breakthrough may lead to non-pharmacological therapies

  • To curb violent tendencies, start young

  • Young women involve parent in abortion when anticipating support

  • Everyday discrimination impacts mental health

  • This is your brain on snacks: Brain stimulation affects craving, consumption

  • Largest ever study of awareness during general anesthesia identifies risk factors and consequences

  •